ClinicalTrials.Veeva

Menu

Little Cigar and Cigarillo Warnings for Youth

UNC Lineberger Comprehensive Cancer Center logo

UNC Lineberger Comprehensive Cancer Center

Status

Completed

Conditions

Little Cigars and Cigarillos (LCC) Use

Treatments

Behavioral: FDA Warnings Text-Only
Behavioral: Surgeon General Text-Only Warnings
Behavioral: FDA warnings + Image

Study type

Interventional

Funder types

Other
Other U.S. Federal agency
NIH

Identifiers

NCT06413797
23-2455
5R01CA260822-03 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study explores the effect of the little cigars and cigarillos (LCC) warnings on youth who currently use, have ever used, or are susceptible to using LCCs. This study will inform the Food and Drug Administration (FDA) implementation of LCC warnings, which can reduce LCC use and lessen tobacco health disparities among youth.

Full description

Cigar use exposes youth to the addictive effects of nicotine during a critical developmental period and increases the risk of multiple cancers and premature death. Recent data indicate that cigars are the second most commonly used tobacco product by youth and that past 30-day cigar use is 7.6%, which translates into 1.1 million high school students. Of the three major types of cigars-large cigars, little cigars, and cigarillos-little cigars and cigarillos (LCCs) are the most commonly used in the US, particularly among younger people. LCC use also contributes to tobacco health disparities, as Black or African American youth use cigars more frequently than other youth. In 2016, the Food and Drug Administration (FDA) deemed LCCs subject to FDA regulation, requiring six rotating text-only warning statements to be on LCC packaging. Previous research has examined the effectiveness of LCC warnings in reducing youth willingness to use LCCs.

Research from studies of cigarette warnings suggests that effective LCC warnings should employ images that illustrate negative health effects associated with use and a larger warning label prominently displayed on the pack. Among youth, health warnings on cigarette packs that contain both text statements and images are more effective and engaging than text-only warnings. However, evidence for cigarette warning labels cannot adequately inform implementation of improved LCC warnings for three reasons: 1) there is no evidence on the effectiveness of the FDA-mandated text-only LCC warnings on behavioral intentions or other outcomes among youth 2)courts have ruled that effective tobacco warnings on one type of tobacco product cannot be used to justify warnings on other types of tobacco, and 3) LCC users have different demographic and consumption profiles than cigarette users include more Black/African Americans and use LCCs on fewer days per month.

Enrollment

928 patients

Sex

All

Ages

15 to 20 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Members of the recruitment panel (we are partnering with a panel provider for the recruitment of all participants)
  2. Agree to provide their honest answers
  3. Susceptible to using LCCs, or have ever used little cigars and/or cigarillos, or currently use little cigar and/or cigarillos in the past 30 days
  4. Age 15 - 20 years old
  5. Currently living in US or US territory
  6. Able to complete 2 surveys that take approximately 15 minutes
  7. Able to complete a 2-minute survey each day for 6 days
  8. Able to verify they are not a bot using CAPTCHA
  9. Able to answer a simple, random math question

Exclusion criteria

  • Not able to verify they are not a bot using Completely Automated Public Turing test to tell Computers and Humans Apart (CAPTCHA).
  • Not able to answer a simple, random math question.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

928 participants in 3 patient groups

FDA warnings + Image
Experimental group
Description:
Participants will receive FDA-proposed LCC warnings with images
Treatment:
Behavioral: FDA warnings + Image
FDA Warnings Text-Only Warnings
Experimental group
Description:
Participants will receive FDA-proposed text-only LCC warnings.
Treatment:
Behavioral: FDA Warnings Text-Only
Surgeon General Text-Only Warnings
Active Comparator group
Description:
Participants will receive Surgeon General text-only LCC warnings.
Treatment:
Behavioral: Surgeon General Text-Only Warnings

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Kristen Jarman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems